Abstract:Background: The efficacy of conventional pharmacotherapy on osteoporosis was limited and accompanied with serious side effects. Epimedium might have the potential to be developed as agents to treat osteoporosis. The present systematic review and meta-analysis integrating Western medicine and Eastern medicine (“WE” medicine) was to evaluate the efficacy of Epimedium on osteoporosis. Methods: Eleven electronic databases were searched to identify the randomized controlled trials (RCTs) comparing Epimedium as an adjunctive or alternative versus conventional pharmacotherapy during osteoporosis. Bone mineral density (BMD), effective rate, and Visual Analog Scale (VAS) were measured as primary outcomes. The secondary outcomes were pain relief time, bone metabolic markers, and adverse events. Research quality evaluation was conducted according to the modified Jadad scale. Review Manager 5.4 was utilized to perform analyses, and the data were pooled using a random-effect or fixed-effect model to calculate the weighted mean difference (WMD), standardized mean difference (SMD), risk ratio (RR), and 95% confidence intervals (CI). Results: Twelve RCTs recruiting 1,017 patients were eligible. Overall, it was possible to verify that, in the Epimedium plus conventional pharmacotherapy group, BMD was significantly improved ( p = 0.03), effective rate was significantly improved ( p = 0.0001), and VAS was significantly decreased ( p = 0.01) over those in control group. When compared to conventional pharmacotherapy, Epimedium used alone improved BMD ( p = 0.009) and effective rate ( p < 0.0001). VAS was lower ( p < 0.00001), and the level of alkaline phosphatase (ALP) was significantly decreased ( p = 0.01) in patients taking Epimedium alone compared with those given conventional pharmacotherapy. Results of subgroup analyses yielded that the recommended duration of Epimedium as an adjuvant was >3 months ( p = 0.03), the recommended duration of Epimedium as an alternative was ≤3 months ( p = 0.002), and Epimedium decoction brought more benefits (SMD = 2.33 [1.92, 2.75]) compared with other dosage forms. No significant publication bias was identified based on statistical tests (t = 0.81, p = 0.440). Conclusions: Epimedium may improve BMD and effective rate and relieve pain as an adjuvant or alternative; Epimedium as an alternative might regulate bone metabolism, especially ALP, with satisfying clinical efficacy during osteoporosis. More rigorous RCTs are warranted to confirm these results.

Research progress in effect of total flavones of Epimedium in Situ on bone and cartilage cells

In Vitro Study of the Effects of Epimedium on Osteoclastic Bone Resorption in Various Oral Mineralized Tissues

Effects of genus Epimedium in the treatment of osteoarthritis and relevant signaling pathways

Effects of total flavonoids and flavonol glycosides from Epimedium koreanum Nakai on the proliferation and differentiation of primary osteoblasts.

Research progress on the extraction technology and activity study of Epimedium polysaccharides

Research progress in anti-osteoporotic effect of plant flavonoids

Advancements in the Biotransformation and Biosynthesis of the Primary Active Flavonoids Derived from Epimedium

A systematic review of the botany, traditional uses, phytochemistry and pharmacology of Epimedium

Resistance of Total Flavones of Epimedium leptorrhizum Stearn on rat Osteoporosis Induced by Retinoic Acid

Total Flavonoids of Herba Epimedii Improves Osteogenesis and Inhibits Osteoclastogenesis of Human Mesenchymal Stem Cells.

Osteoprotective effects of flavonoids: Evidence from in vivo and in vitro studies (Review)

Pharmacological actions of the bioactive compounds of Epimedium on the male reproductive system: current status and future perspective

Epimedium Linn: A Comprehensive Review of Phytochemistry, Pharmacology, Clinical Applications and Quality Control

Comprehensive review of the traditional uses and the potential benefits of epimedium folium

Cancer-Related Therapeutic Potential of Epimedium and Its Extracts

Epimedium for Osteoporosis Based on Western and Eastern Medicine: An Updated Systematic Review and Meta-Analysis

Research Progress in the Prevention and Treatment of Osteoporosis Using Chinese Medicinal Herb Eucommia ulmoides Oliver

Effects of Total Flavonoids of Epimedium on Bone Marrow Adipose Tissue in Ovariectomized Rats

Comparative Effects of Er-Xian Decoction, Epimedium Herbs, and Icariin with Estrogen on Bone and Reproductive Tissue in Ovariectomized Rats

Unveiling the Therapeutic Potential of Herba Epimedii: Enhancing Bone Healing Through Cytoskeletal Regulation of RhoA/Rock1 Pathway

The Bioactive Compounds of Epimedium and Their Potential Mechanism of Action in Treating Osteoporosis: A Network Pharmacology and Experimental Validation Study